Ticker Details
Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
IPO Date:	March 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 4.73%
Avg Daily Range (30 D):	$1.06 | 3.39%
Avg Daily Range (90 D):	$1.00 | 3.49%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.87M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	172
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	635
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$1.99M
Avg Institutional Trade (90 D):	$2.89M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.21M
Avg Closing Trade (30 D):	$2.69M
Avg Closing Trade (90 D):	$3.85M
Avg Closing Volume:	127.24K

News

May 26, 2026 @ 5:00 PM Duchenne Muscular Dystrophy Clinical Trial Pipelin... Source: Delveinsight

May 10, 2026 @ 11:01 AM Capricor's Insider Just Sold Big — Her Opti... Source: Seena Hassouna

Dec 3, 2025 @ 7:21 PM Capricor Stock Soars, Shkreli Is Short: Here's Wha... Source: Erica Kollmann

Sep 25, 2025 @ 3:16 PM Why Capricor Therapeutics Stock Is Surging Today Source: Alex Perry

Sep 15, 2025 @ 7:58 PM Shareholders of Capricor Therapeutics, Inc. Should... Source: The Gross Law Firm

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.59	$-.54
Diluted EPS		$-.59	$-.54
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-33.94M	$-24.57M
Operating Income / Loss		$-36.77M	$-26.28M
Cost of Revenue
Net Cash Flow		$-182.43M	$-3.73M
PE Ratio

Splits
Jun 05, 2019	1:10
Nov 21, 2013	1:50
Feb 09, 2007	1:10
Apr 05, 2005	1:20